Search Share Prices
HIK Shares - UK Markets Surge as Healthcare Sector Gains; BP’s Strategy Under the Microscope
Nasdaq 100, FTSE 100, S&P 500, Dow Jones Industrial Average. Read Richard J. Hunter's latest article on Investing.com UK.
Hikma shares fall as margins disappoint, despite revenue beat
However, Hikma’s core EBIT for the year stood at $719 million, with a margin of 22.8%, slightly below the consensus estimate of 23.4%. Hikma’s 2H24 results showed a 3% sales beat, primarily driven by ...
Investing in Hikma Pharmaceuticals (LON:HIK) five years ago would have delivered you a 38% gain
For example, the Hikma Pharmaceuticals PLC (LON:HIK) share price is up 23% in the last 5 years, clearly besting the market return of around 3.1% (ignoring dividends). However, more recent returns ...
Investing in Hikma Pharmaceuticals (LON:HIK) five years ago would have delivered you a 38% gain
For example, the Hikma Pharmaceuticals PLC (LON:HIK) share price is up 23% in the last 5 years, clearly besting the market return of around 3.1% (ignoring dividends). However, more recent returns ...
Hikma Pharmaceuticals PLC (HIK.L)
In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K. dividend aristocrats. In recent years, investors have turned away from UK ...